The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 11, 2022
Filed:
Sep. 17, 2020
Applicants:
Incyte Corporation, Wilmington, DE (US);
Incyte Holdings Corporation, Wilmington, DE (US);
Inventors:
Bhavnish Parikh, Avondale, PA (US);
Bhavesh Shah, San Antonio, TX (US);
Krishnaswamy Yeleswaram, Landenberg, PA (US);
Assignee:
INCYTE HOLDINGS CORPORATION, Wilmington, DE (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/519 (2006.01); A61K 47/24 (2006.01); A61K 47/06 (2006.01); A61K 47/36 (2006.01); A61K 47/26 (2006.01); A61K 47/14 (2017.01); A61K 9/00 (2006.01); A61K 9/107 (2006.01); A61K 47/10 (2017.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); A61K 9/0014 (2013.01); A61K 9/107 (2013.01); A61K 47/06 (2013.01); A61K 47/10 (2013.01); A61K 47/14 (2013.01); A61K 47/24 (2013.01); A61K 47/26 (2013.01); A61K 47/36 (2013.01);
Abstract
This invention relates to pharmaceutical formulations for topical skin application comprising (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile, or a pharmaceutically acceptable salt thereof, and use in the treatment of skin disorders.